[1] Saif A.  Primary hyperparathyroidism presenting with acute pancreatitis and asymptomatic bone involvement[J]. Clin Cases Miner Bone Metab, 2015, 12(2): 199-201.   doi: 10.11138/ccmbm/2015.12.2.199
[2] 桑尚, 张智长, 覃澍, 等.  甲状旁腺功能亢进症性骨病26例分析[J]. 中国骨与关节杂志, 2016, 5(9): 690-694.   doi: 10.3969/j.issn.2095-252X.2016.09.008
Sang S, Zhang ZC, Qin S, et al.  Strategy for the diagnosis and treatment of bone diseases caused by primary hyperparathyroidism[J]. Chin J Bone Joint, 2016, 5(9): 690-694.   doi: 10.3969/j.issn.2095-252X.2016.09.008
[3]

刘宝岳, 左庆瑶, 赵海涛. 原发性甲状旁腺功能亢进骨病的病理诊断[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(2): 174−177. DOI: 10.3969/j.issn.1674−2591.2016.02.011.

Liu BY, Zuo QY, Zhao HT. Pathological diagnosis of primary hyperparathyroidism[J]. Chin J Osteoporosis Bone Miner Res, 2016, 9(2): 174−177. DOI: 10.3969/j.issn.1674−2591.2016.02.011.
[4] 朱瑞森, 罗琼, 陆汉魁, 等.  117例原发性甲状旁腺功能亢进症的核素骨显像分析[J]. 中华核医学杂志, 2010, 30(1): 38-41.   doi: 10.3760/cma.j.issn.0253-9780.2010.01.010
Zhu RS, Luo Q, Lu HK, et al.  Clinical study of bone imaging in 117 cases with primary hyperparathyroidism[J]. Chin J Nucl Med, 2010, 30(1): 38-41.   doi: 10.3760/cma.j.issn.0253-9780.2010.01.010
[5] Yang Q, Li JM, Yang ZP, et al.  Skeletal lesions in primary hyperparathyroidism[J]. Am J Med Sci, 2015, 349(4): 321-327.   doi: 10.1097/MAJ.0000000000000441
[6] Bandeira F, Cusano NE, Silva BC, et al.  Bone disease in primary hyperparathyroidism[J]. Arq Bras Endocrinol Metabol, 2014, 58(5): 553-561.   doi: 10.1590/0004-2730000003381
[7] 杨硕, 郑穗生, 姚文君, 等.  慢性肾功能衰竭继发肾性骨病的影像学诊断[J]. 安徽医学, 2017, 38(6): 780-782.   doi: 10.3969/j.issn.1000-0399.2017.06.033
Yang S, Zheng SS, Yao WJ, et al.  Imaging diagnosis of secondary renal osteopathy in chronic renal failure[J]. Anhui Med J, 2017, 38(6): 780-782.   doi: 10.3969/j.issn.1000-0399.2017.06.033
[8] 方义杰, 洪国斌, 卢慧芳, 等.  长期血液透析继发棕色瘤的影像学表现[J]. 中国CT和MRI杂志, 2017, 15(1): 141-143.   doi: 10.3969/j.issn.1672-5131.2017.01.045
Fang YJ, Hong GB, Lu HF, et al.  Imaging findings of brown tumor secondary to long-term hemodialysis[J]. Chin J CT MRI, 2017, 15(1): 141-143.   doi: 10.3969/j.issn.1672-5131.2017.01.045
[9] 黄之杰, 陈建忠, 王庆旭, 等.  肾性骨病核素骨显像结果分析[J]. 西南国防医药, 2012, 22(2): 158-160.   doi: 10.3969/j.issn.1004-0188.2012.02.017
Huang ZJ, Chen JZ, Wang QX, et al.  Radionuclide bone imaging results of renal osteopathy[J]. Med J Natl Defending Forces Southwest China, 2012, 22(2): 158-160.   doi: 10.3969/j.issn.1004-0188.2012.02.017
[10] 白荣杰, 钱占华, 叶薇, 等.  多发棕色瘤X线、CT及MRI表现[J]. 临床放射学杂志, 2015, 34(3): 420-423.   doi: 10.13437/j.cnki.jcr.2015.03.027
Bai RJ, Qian ZH, Ye W, et al.  Radiography, CT and MR findings of multiple brown tumors caused by primary hyperparathyroidism[J]. J Clin Radiol, 2015, 34(3): 420-423.   doi: 10.13437/j.cnki.jcr.2015.03.027
[11] 王勇, 胡新杰, 任伯绪.  影像学对原发性甲状旁腺功能亢进骨病的诊断价值[J]. 医学影像学杂志, 2014, 24(2): 205-208.
Wang Y, Hu XJ, Ren BX.  The diagnostic value of imaging to bone disease resulted from the primary hyperparathyroidism[J]. J Med Imaging, 2014, 24(2): 205-208.
[12] Misiorowski W, Czajka-Oraniec I, Kochman M, et al.  Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism[J]. Endocrine, 2017, 58(2): 380-385.   doi: 10.1007/s12020-017-1414-2
[13] Das KJ, Sehgal AK, Jaiman A, et al.  Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma[J]. Indian J Nucl Med, 2015, 30(3): 263-265.   doi: 10.4103/0972-3919.158541
[14] 孙鹏, 杨强, 李建民.  棕色瘤的临床诊治分析及其转归[J]. 中国矫形外科杂志, 2014, 22(19): 1737-1743.   doi: 10.3977/j.issn.1005-8478.2014.19.02
Sun P, Yang Q, Li JM.  Analysis of the clinical management and treatment outcomes of brown tumors[J]. Orthop J China, 2014, 22(19): 1737-1743.   doi: 10.3977/j.issn.1005-8478.2014.19.02
[15] Queiroz IV, Queiroz SP, Medeiros R Jr, et al.  Brown tumor of secondary hyperparathyroidism: surgical approach and clinical outcome[J]. Oral Maxillofac Surg, 2016, 20(4): 435-439.   doi: 10.1007/s10006-016-0575-0
[16] Blake GM, Puri T, Siddique M, et al.  Site specific measurements of bone formation using [18F]sodium fluoride PET/CT[J]. Quant Imaging Med Surg, 2018, 8(1): 47-59.   doi: 10.21037/qims.2018.01.02
[17]

Win AZ, Aparici CM. Normal SUV values measured from NaF18- PET/CT bone scan studies[J/OL]. PLoS One, 2014, 9(9): e108429[2018-05-10]. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108429. DOI: 10.1371/journal.pone.0108429.
[18] 程旭, 李永军, 徐兆强, 等.  99mTc-MDP全身骨扫描在肾性骨病中的显像特点探讨[J]. 南京医科大学学报: 自然科学版, 2014, 34(9): 1260-1263.   doi: 10.7655/NYDXBNS20140923
Cheng X, Li YJ, Xu ZQ, et al.  Imaging characteristics of 99mTc-MDP whole body bone scan in renal osteopathy[J]. Acta Univ Med Nanjing: Nat Sci, 2014, 34(9): 1260-1263.   doi: 10.7655/NYDXBNS20140923
[19] Grellier JF, Lussato D, Queneau M, et al.  Secondary hyperparathyroidism with "superscan-like" hypermetabolic FDG PET/CT pattern[J]. Clin Nucl Med, 2015, 40(11): 888-889.   doi: 10.1097/RLU.0000000000000952
[20] Andersen KF, Albrecht-Beste E.  Brown tumors due to primary hyperparathyroidism in a patient with parathyroid carcinoma mimicking skeletal metastases on 18F-FDG PET/CT[J]. Diagnostics (Basel), 2015, 5(3): 290-293.   doi: 10.3390/diagnostics5030290
[21] Yuan LL, Liu J, Kan Y, et al.  The diagnostic value of 11C-methionine PET in hyperparathyroidism with negative 99mTc-MIBI SPECT: a meta-analysis[J]. Acta Radiol, 2017, 58(5): 558-564.   doi: 10.1177/0284185116661878
[22] Kluijfhout WP, Pasternak JD, Drake FT, et al.  Use of PET tracers for parathyroid localization: a systematic review and meta-analysis[J]. Langenbecks Arch Surg, 2016, 401(7): 925-935.   doi: 10.1007/s00423-016-1425-0
[23] Weber T, Gottstein M, Schwenzer S, et al.  Is C-11 methionine PET/CT Able to localise sestamibi-negative parathyroid adenomas?[J]. World J Surg, 2017, 41(4): 980-985.   doi: 10.1007/s00268-016-3795-4